BioHarvest Sciences Files 6-K Report

Ticker: BHST · Form: 6-K · Filed: Sep 12, 2024

Sentiment: neutral

Topics: regulatory-filing, corporate-history, sec-update

Related Tickers: BHSC

TL;DR

BHSC filed a 6-K, confirming 20-F annual report filing and corporate history updates.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on September 12, 2024, reporting for the month of September 2024. The company, previously known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc., is incorporated in British Columbia, Canada, and its principal executive offices are located in Vancouver. The filing indicates the company will file its annual reports under Form 20-F.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s reporting status and corporate history, which is important for investors tracking the company's regulatory compliance and evolution.

Risk Assessment

Risk Level: low — This filing is a routine regulatory update and does not contain significant new financial or operational information that would immediately impact risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report for the month of September 2024 and to indicate that the registrant files its annual reports under cover of Form 20-F.

What were BioHarvest Sciences Inc.'s former company names?

BioHarvest Sciences Inc. was formerly known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc.

When did the company change its name from Midnight Star Ventures Corp.?

The company changed its name from Midnight Star Ventures Corp. on October 8, 2017.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

BioHarvest Sciences Inc.'s principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 200 words · 1 min read · ~1 pages · Grade level 17.5 · Accepted 2024-09-12 15:44:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: September 12, 2024 /s/ Zaki Rakib Name: Zaki Rakib Title: President

View on Read The Filing